ABOUT OUR COMPANY

 

Legal Note

 

Impressum und Pflichtangaben gemäß § 5 TMG

Name, Rechtsform und Sitz des Anbieters

CTL Europe GmbH

Hans-Boeckler-Straße 19-29

53225 Bonn

Vertreten durch den Geschäftsführer

Prof. Dr. Paul Lehmann

Kontakt

Telefon: -49 (0) 228 85 44 78-0

E-Mail: ctl-europe@immunospot.eu

Internetadresse: www.immunospot.eu

Handelsregister

Eintrag im Handelsregister:

Amtsgerichts Bonn

Registernummer: HRB-16468

Umsatzsteuer-Ident.-Nr.

UStIDE DE227818386

 

Disclaimer

Der Seiteninhalt dieser Internetpräsens wurde mit größtmöglicher Sorgfalt erstellt. Ungeachtet dessen können wir keine Gewähr für die Richtigkeit, Vollständigkeit und Aktualität der Inhalte übernehmen. Aufgrund gesetzlicher Vorgaben sind wir ausschließlich für unsere eigenen Inhalte auf diesen Webseiten verantwortlich.

Verlinkte Inhalte

Für den Inhalt der verknüpften Webseiten sind wir nicht verantwortlich und machen uns den Inhalt der verlinkten Webseiten nicht zu eigen. Für illegale, fehlerhafte oder unvollständige Inhalte sowie für Schäden, die durch die Nutzung oder Nichtnutzung der Informationen entstehen, haftet allein der Anbieter der Webseite, auf die verwiesen wurde. Die Haftung desjenigen, der lediglich auf die Veröffentlichung durch einen Hyperlink hinweist, ist ausgeschlossen. Für fremde Inhalte sind wir nur dann verantwortlich, wenn wir von den Inhalten ihnen positive Kenntnis haben oder eigene Prüfpflichten verletzen, insbesondere wenn es sich um etwaige rechtswidrige bzw. strafbare Inhalte handelt, und es technisch möglich und zumutbar ist, deren Nutzung zu verhindern.

Copyright

Alle verwendeten Inhalte, Texte, Bilder und Grafiken sowie das Layout dieser Webseite unterliegen dem Urheberrecht. Die Verwendung, Reproduktion, Veränderung oder Weitergabe einzelner Inhalte, Teilen von der oder der kompletten Internetseite ist nur nach vorheriger, schriftlich erteilter Genehmigung zulässig. Dies gilt ebenso für die unerlaubte Einbindung einzelner Inhalte oder Teilen von der oder der kompletten Internetseite auf Webseiten anderer Betreiber. Die Rechte zur Privatkopie, soweit sie nicht einer gewerblichen Nutzung dienen, sind hiervon unberührt wie auch die Rechte nach § 44 a UrhG ff.

Unberechtigte Vervielfältigung von urheberechtlich geschützten Inhalten gilt nach § 106 UrhG als Straftat.

 

Bildnachweis:

© selvanegra istockphoto.com, © nicolas_ istockphoto.com, © AlexRaths istockphoto.com, © diamant24 istockphoto.com, © Von Jarun Ontakrai shutterstock.com, © sruilk shutterstock.com, © 4X-image istockphoto.com, © 7postman istockphoto.com, © Ugreen istockphoto.com, © extender_01 shutterstock.com, © Kateryna Kon shutterstock.com, © luismmolina istockphoto.com, © luchschen istockphoto.com, © kasto80 istockphoto.com, © dra_schwatz istockphoto.com, © Ugreen istockphoto.com, © lightwise 123RF.com, © Liya Graphics shutterstock.com, © wacomka istockphoto.com, © mathagraphics shutterstock.com, © xrender istockphoto.com, © 306 shutterstock.com, © anyaivanova istockphoto.com, © AlexRaths istockphoto.com



 


 

Ordering Information: 

When placing an order, Customer must submit a valid Purchase Order – including information such as shipping address, phone number, name of whom the shipment should be addressed to, a billing address, VAT number and a method of payment.
 For ePBMC® Products from specific characterized PBMC from random, healthy donors, CTL will choose the correct PBMC lots, or the customer may search the CTL online ePBMC® database at epbmc.immunospot.com. 
For Cryopreserved PBMC Products already in inventory, CTL will ship the Product as indicated on the order confirmation. For custom Products, CTL may require additional lead time to recruit donors that meet Customer's specifications. Lead time will be discussed upon order request. 
Cancellation/Change Orders must be made in writing and agreed to by authorized personnel of both CTL and Customer. 
Orders may not be canceled or changed less than 24 hours prior to the scheduled dispatch time. The Customer is responsible for paying the full order prices for any orders canceled less than 24 hours prior to the scheduled dispatch time. 
Donor screening tests are performed for each PBMC lot at the collection site, and all Cryopreserved PBMC Products are shipped already tested.

Currently Available Serological Testing:

  • ABO/Rh
  • Syphilis
  • Antibody Screen
  • Anti-CMV (if requested)

Currently Available Infectious Disease Testing:

  • Hepatitis B Core Antibody (Anti-HBc EIA)
  • Hepatitis B Surface Antigen (HBsAg EIA)
  • Hepatitis C Virus Antibody (Anti-HCV EIA)
  • Human Immunodeficiency Virus Antibody (HIV 1/2 plus O)
  • Human T-Lymphotropic Virus Antibody (HTLV-I/II)
  • HIV-1/HCV/HBV Nucleic Acid Testing
  • WNV Nucleic Acid
  • Trypanasoma cruzi Antibody (Selective Chagas disease testing, a single lifetime test per donor)

Use of Goods:

  • 1.All Products received from CTL are for research purposes only; not for use in diagnostic or therapeutic procedures, or on human beings or animals, or for private use. Customer shall not transfer the Products, components, or materials made using these Products, or, use these products for Commercial Purposes. Commercial Purposes includes (a) use of the Products or their components in manufacturing; (b) use of the Products or their components for therapeutic or diagnostic purposes; 3) resale of the Products or their components.
  • 2.CTL will not be liable for the improper use of any Product provided. CTL delivers Products to academic teaching and research institutions, commercial enterprises, and scientific researchers for research use only. Should CTL receive notice of improper use of any Products, CTL may refuse future delivery of Products and may terminate the filling of any pending orders.

 

Indemnification:

Customer and CTL shall fully, completely, and unconditionally indemnify, defend and hold harmless the other party, and such other party’s directors, officers, employees, agents, and affiliates, from and against any and all claims, actions, liabilities, costs and expenses (including without limitation judgment and settlement costs, court costs, and attorneys’ fees) arising out of or relating to, or alleged to arise out of or relate to, negligent or intentional acts or omissions of the indemnifying party or any failure by the indemnifying party to perform any obligation or covenant of the indemnifying party in connection with these Terms and Conditions or the use or misuse of the Products.

Warranty

CTL warrants that the Products will perform according the Products’ specifications. CTL will replace all Products free of charge that do not meet the specifications claimed on the Product Data Sheet provided to Customer. Products that have been misused or considered to be unusable due to improper storage or handling will not be covered under CTL’s warranty. Due to the various factors affecting research test results, CTL does not warrant that any of the Products are fit for any particular purpose. Products are sold with the understanding that the Customer will determine if the Product is suitable for Customer’s application.

CTL guarantees the performance of Cryopreserved PBMC only if the appropriate CTL Serum-free Media Products are used exclusively and the recommended storage and use protocols are followed. Cell and Media performance is not guaranteed if any modifications are made to test systems.

For Cryopreserved Products, Customer shall inspect the delivered Products and notify CTL of any claims for shortages, defects, or damages within 24 hours after receipt of the Product by Customer. Customer must supply pictures and/or other type of evidence of the aforementioned and ship the Products back to CTL per CTL’s instructions and at CTL’s cost. Any Cryopreserved Product not rejected within the 24 hour period will be deemed to be accepted by Customer.

Safety Statement

THESE PRODUCTS ARE FOR RESEARCH USE ONLY; are not intended for direct therapeutic or diagnostic use in humans or animals, or for use in in vitro diagnostic procedures.

WARNING:

CTL Cryopreserved PBMC Products CONTAIN HUMAN SOURCE MATERIAL. TREAT AS POTENTIALLY INFECTIOUS.

Each donor is tested at collection site and found non-reactive (negative) by an FDA-approved method for the presence of HIV-I, Hepatitis B Virus, Hepatitis C Virus, STS and CHAGAS.

However, testing cannot offer complete assurance that HIV-1, Hepatitis B Virus, and Hepatitis C Virus are absent. All human-sourced Products should be handled at the Biological Safety Level 2 to minimize exposure of potentially infectious Products, as recommended in the CDC-NIH Manual, Biosafety in Microbiological and Biomedical Laboratories, revised 2009.


 

 

 

CTL Europe GmbH 
Hans-Boeckler-Str. 19-29 | 53225 Bonn, Germany
+49 228 85 44 78-0 | +49 228 85 44 78-22 Fax                     
Privacy Policy | Imprint | Sitemap
ctl-europe@immunospot.eu | www.immunospot.eu

© 2017 CTL Europe GmbH